Replies to post #38442 on Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

May 27, 2019 Patent expires and others allowed to launch.

Why is Lupin not entitled to 6 months exclusivity???

Lupin received Seroquel XR approval AFTER IPCI and captured 18% of the market while IPCI got $hit.

Had MNK done it's job and captured even 5% of the market IPCI would now be a $6.00 stock PRE-SPLIT.

[numbersarefun]

IPCI's Ranexa NOT among 4 FDA Approvals 5/28/2019. FDA did give final approval to the tentatively approved applications on 5/28/2019 to: 1) Actavis, 2) Ajanta, 3) Cipla, and 4) SunPharma. Lupin was the first to file and launched 3 months earlier. All patents for the drug expired 5/27/2019, so Lupin only got 90 days exclusivity, instead of 180 days.

IPCI's website is currently missing ANDA pipeline page. There is only IPCI's homepage with OxyER and Regabatin listed and no page dedicated to the pipeline. I find no link or webpage to an ANDA pipeline.